Cite
HARVARD Citation
Lwin, M. et al. (2020). Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?. Rheumatology advances in practice. 4 (2), p. . [Online].